Marinus Pharmaceuticals Inc (NAS:MRNS)
$ 1.79 0.05 (2.89%) Market Cap: 98.60 Mil Enterprise Value: 91.54 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 40/100

Marinus Pharmaceuticals Inc Annual Shareholders Meeting Transcript

May 27, 2020 / 02:30PM GMT
Release Date Price: $12.28 (-3.46%)
Operator

Good morning. Welcome to the Annual Meeting of Stockholders for Marinus Pharmaceuticals. I will now hand the call over to Dr. Scott Braunstein, Chief Executive Officer of Marinus Pharmaceuticals. You may begin, Scott.

Scott Braunstein
Marinus Pharmaceuticals, Inc. - CEO, President & Director

Good morning and welcome to the Annual Meeting of Stockholders of Marinus Pharmaceuticals, Inc. I am Scott Braunstein, Chief Executive Officer and a director of Marinus, and I will be acting as chairman of this meeting.

To all of our stockholders, I want to wish the best for you, your families and your communities during these uncertain and unprecedented times. At this time, the meeting is called to order.

I would like to introduce the management team present today. Ed Smith, Vice President, Chief Financial Officer, Secretary and Treasurer; and Sasha Damouni Ellis, Vice President, Investor and Corporate Communications. Mr. Smith will be serving as secretary and inspector of elections for this meeting. We are also joined today by Beth Kane from KPMG

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot